MRNS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: MRNS Shares Outstanding History and MRNS YTD Return |
MRNS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: MRNS Shares Outstanding History and MRNS YTD Return |
MRNS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+15.80% CAGR Mouse over chart for data details
|
MRNS Stock Price Chart |
About Marinus Pharmaceuticals Inc |
Marinus Pharmaceuticals is a pharmaceutical company focused on the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus. The U.S Food and Drug Administration approved the use of ZTALMY (ganaxolone) oral suspension for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder in patients two years of age and older. Co. is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral. Ganaxolone is a synthetic analog of allopregnanolone, an endogenous neurosteroid. We show 39 historical shares outstanding datapoints in our MRNS shares outstanding history coverage, used to compute MRNS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MRNS market cap history over the course of time is important for investors interested in comparing MRNS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MRNS versus a peer is one thing; comparing MRNS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MRNS can fluctuate over the course of history. With this page we aim to empower investors researching MRNS by allowing them to research the MRNS market cap history. |
MRNS Current Stock Quote |
Free MRNS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
MRNS Share Performance |
Market Cap Peers |
Marinus Pharmaceuticals (MRNS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MRSN Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.